-
Prioritizing Health Equity
As health inequities affect vulnerable populations, healthcare organizations must shift to a health equity centered, population health approach, according to a recent position paper from the National Academy of Medicine.
-
Northwestern Hospitals Among the Best in Latest U.S. News Rankings
Four Northwestern Medicine hospitals have been recognized by U.S. News & World Report in its 2020-21 Best Hospitals rankings, with Northwestern Memorial Hospital named among the top 10 hospitals in the U.S.
-
Protein May Improve Immunotherapy for Medulloblastoma
A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.
-
Shortened Resident Shifts Didn’t Decrease Errors
Residents working shifts of 16 hours or less didn’t make fewer errors than residents assigned to 24-hour shifts, according to a recent study published in NEJM.
-
Mitochondrial Metabolism Shows Promise as Target for Cancer Therapy
Northwestern Medicine investigators have discovered that the growth of cancerous tumors requires the activation of a specific biochemical process within the mitochondria of tumor cells, showing potential as a new target for cancer therapy.
-
Continuous Glucose Monitoring May Help Reduce Hypoglycemia
In older adults with type 1 diabetes, continuous blood glucose monitoring was more effective in reducing hypoglycemia than standard blood glucose monitoring, according to recent findings published in JAMA.
-
Medical Student Helps Organize Outreach for Older Adults Experiencing COVID-19 Isolation
Emma Office, a rising second year medical student and co-leader of the student COVID-19 volunteer effort at Feinberg, helped organize a successful phone call outreach program for older adults at risk of experiencing social isolation during the pandemic.
-
Drug Shortens Flu Recovery in Vulnerable Patients
Patients with influenza at risk of complications recovered more quickly after early treatment with the drug baloxavir marboxil, according to a study published in The Lancet Infectious Diseases.
-
New Inhibitor Starves HIV
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
-
Protein Unexpectedly Impacts Intracellular Transport in Neurons
Northwestern Medicine investigators have discovered that a specific protein known for its role in cell division also impacts the direction of intracellular transport in neurons.
-
New Therapy Extends Breast Cancer Survival Rate, Prevents Reoccurrence
A new immunotherapy developed by investigators at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer.
-
Alumni Connect with Students for ‘Heart-to-Hearts’
Virtual Heart-to-Hearts connects medical students with Feinberg alumni for conversations about medical specialties, residency applications and more.
-
COVID-19 Complicates Cancer Treatment
Cancer patients with other comorbidities have a higher risk of dying from complications due to COVID-19, and should discuss the risks and benefits of continuing cancer treatment with their physician, according to a recent study.
-
Novel Drug Improves Survival in Advanced Prostate Cancer
A novel drug called enzalutamide may extend overall survival for men with nonmetastatic, castration-resistant prostate cancer, according to findings from clinical trial published in The New England Journal of Medicine.
-
Support Tool Aims to Streamline Decision Process for Cesarean Delivery
A new patient-centered decision support tool aims to help pregnant women decide whether they prefer trial-of-labor or a repeat cesarean delivery after having a prior cesarean.
-
Critical Function of Cilia Protein Discovered
A protein gives motile cilia part of their structure, according to a recent Northwestern Medicine study.
-
Chemotherapy Drug Mitigates Allergic Response
A drug originally designed as cancer therapy virtually eliminated allergic reactions in moderate cases and significantly lessened the risk of death in severe cases, according to a new study in animal models.
-
Chimeric Toxin Slows Cancer Growth
A novel compound using diphtheria toxin to attack a signaling pathway implicated in as many as 50 percent of cancers slowed tumor growth, according to a recent study.
-
New Role for RNA Splicing in Insulin Regulation
The gene transcription machinery that controls circadian rhythms also regulates insulin release in the pancreas, according to a Northwestern Medicine study.
-
Exploring Protein Vital for Bone Marrow Transplants
A protein called mDia2 is vital for proper bone marrow transplantation, according to a new study.
